| Home : Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis |
|
Mar 20
2018 |
Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis |
|
BOSTON, March 20, 2018 /PRNewswire-USNewswire/ -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced today that Novartis will have access to commercially develop their... |
|
|
|
| Source:https://www.prnewswire.com/news-releases/harvard-bioengineers-biomaterial-based-cancer-immunotherapies-to-be-developed-by-novartis-300615921.html |
| |
|
Related News
|
» Keystroke Now Exclusive Worldwide Distributor of Stonefield Query for Act
» Brammer Bio Expands Leadership Team for Commercial Readiness
|
